Titan Pharmaceuticals Inc
TTNPDelisted Oct 2, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000910267
Titan Pharmaceuticals Inc was delisted on Oct 2, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 18 institutions reported holding it in 13F filings for Q3 2025, worth $107.1K in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Titan Pharmaceuticals Inc as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +3 vs. Q3 2022
- Shares held
- 968.0K
- −86.4K (−8.2%) vs. Q3 2022
- Total value
- $757.9K
- −$378.1K (−33.3%) vs. Q3 2022
- New holders
- 6
- 4 more added
- Sold out
- 3
- 6 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TTNP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 5 | $69 |
| Q1 2026 | 6 | $130 |
| Q4 2025 | 4 | $154 |
| Q3 2025 | 18 | $107.1K |
| Q2 2025 | 20 | $158.3K |
| Q1 2025 | 17 | $51.9K |
| Q4 2024 | 15 | $9.41K |
| Q3 2024 | 16 | $88.5K |
| Q2 2024 | 18 | $179.3K |
| Q1 2024 | 17 | $230.0K |
| Q4 2023 | 24 | $408.2K |
| Q3 2023 | 27 | $497.8K |
| Q2 2023 | 25 | $632.7K |
| Q1 2023 | 22 | $787.4K |
| Q4 2022 | 23 | $757.9K |
| Q3 2022 | 21 | $1.14M |
| Q2 2022 | 24 | $371.0K |
| Q1 2022 | 24 | $1.24M |
| Q4 2021 | 24 | $430.0K |
| Q3 2021 | 22 | $722.0K |
| Q2 2021 | 23 | $1.51M |
| Q1 2021 | 24 | $988.1K |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Titan Pharmaceuticals Inc; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Westside Investment Management, Inc. | 4 | $0 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 61 | $0 | 0.00% | +61 | New |
| Newbridge Financial Services Group, Inc. | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Caldwell Sutter Capital, Inc. | 2 | $2 | 0.00% | +2 | New |
| Advisor Group Holdings, Inc. | 37 | $18 | 0.00% | +23+164.3% | Added |
| Morgan Stanley | 28 | $22 | 0.00% | −12−30.0% | Reduced |
| Global Wealth Strategies & Associates | 40 | $31 | 0.00% | +40 | New |
| BlackRock Inc. | 60 | $47 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 77 | $60 | 0.00% | +2+2.7% | Added |
| UBS Group AG | 165 | $129 | 0.00% | −11,011−98.5% | Reduced |
| The PNC Financial Services Group, Inc. | 200 | $156 | 0.00% | +200 | New |
| Bank of America Corp | 206 | $161 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 303 | $237 | 0.00% | +303 | New |
| FMR LLC | 342 | $268 | 0.00% | +341+34,100.0% | Added |
| Level Financial Advisors, Inc. | 987 | $1.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,612 | $1.00K | 0.00% | +1,612 | New |
| Virtu Financial LLC | 20,080 | $16.0K | 0.00% | −8,251−29.1% | Reduced |
| State Street Corp | 38,287 | $30.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 63,965 | $50.0K | 0.00% | −127−0.2% | Reduced |
| Vanguard Group Inc | 82,051 | $64.3K | 0.00% | +127+0.2% | Added |
| Renaissance Technologies LLC | 134,410 | $105.0K | 0.00% | −10,300−7.1% | Reduced |
| Truist Financial Corp | 625,089 | $489.5K | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 14 | – | – | −830−98.3% | Reduced |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −28,025−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −17,467−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −13,076−100.0% | Sold out |
| American Portfolios Advisors | – | – | – | – | Not filed |